Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease.
Katsuhiro YoshimuraYuzo SuzukiYusuke InoueKoji NishimotoKazutaka MoriMasato KarayamaHironao HozumiKazuki FuruhashiNoriyuki EnomotoTomoyuki FujisawaYutaro NakamuraNaoki InuiKoushi YokomuraShiro ImokawaTakafumi SudaPublished in: PloS one (2018)
Serum Aspergillus-galactomannan antigen was detected in patients with COPD, and elevated serum Aspergillus-galactomannan antigen was associated with severe AE-COPD.